Cannabis rescheduling keeps resurfacing in headlines, then vanishing without action. This feature breaks down how federal officials repeatedly float reform language, let deadlines pass, and leave the law untouched. By tracing the mechanics behind the stall, the piece exposes why delay is intentional, who benefits from it, and why cannabis reform remains trapped in federal limbo.
High Stakes: The DEA’s Potent Gamble on Cannabis Destiny
In a moment teeming with potential, the DEA contemplates a monumental shift in cannabis's legal status, sparking debates and hopes across the nation. Will this move herald a new era of recognition and research for cannabis, or will it be another missed opportunity in the ongoing struggle for rational drug policy?